Use of pre-exposure prophylaxis increases the odds of condomless anal sex among young men who have sex with men (MSM) of colour
Richard A. Crosby A B E , Michele D. Kipke C D and Katrina Kubicek CA College of Public Health at the University of Kentucky, 111 Washington Avenue, Lexington, KY 40506, USA.
B Kinsey Institute for Research in Sex, Gender, and Reproduction, Lindley Hall, 150 S. Woodlawn Avenue, Bloomington, IN 47405, USA.
C Community, Health Outcomes and Intervention Research Program, The Saban Research Institute, Children’s Hospital Los Angeles, 4661 Sunset Boulevard, LA 90027, USA.
D Department of Preventive Medicine, Keck School of Medicine, University of Southern California, 1975 Zonal Avenue, LA 90033, USA.
E Corresponding author. Email: crosbyr3@gmail.com
Sexual Health 17(1) 100-101 https://doi.org/10.1071/SH19065
Submitted: 11 April 2019 Accepted: 13 August 2019 Published: 8 November 2019
Abstract
This study tested the hypothesis that people using pre-exposure prophylaxis (PrEP) would be more likely to report condomless anal sex than those not taking PrEP. Data were from an ongoing study conducted with a cohort of Black and Latino young men who have sex with men (YMSM) recruited in Los Angeles (CA, USA). Of the 399 YMSM in the sample, 14% were currently using PrEP. Using three different measures of condom use, across two different recall periods all except one test result supported an inverse relationship between PrEP and condom use for anal sex. Tests of a risk index provided further significant findings supporting this hypothesis.
Additional keywords: condom displacement, public health, sexually transmissible infections.
References
[1] Buchbinder SP, Glidden DV, Liu AY, McMahan V, Guanira JV, Mayer KH, et al HIV pre-exposure prophylaxis in men who have sex with men and transgendered women: a secondary analysis of a phase 3 randomised controlled efficacy trial. Lancet Infect Dis 2014; 14 468–75.| HIV pre-exposure prophylaxis in men who have sex with men and transgendered women: a secondary analysis of a phase 3 randomised controlled efficacy trial.Crossref | GoogleScholarGoogle Scholar | 24613084PubMed |
[2] Office of National AIDS Policy. National HIV/AIDS strategy: updated to 2020. Available online at: https://www.hiv.gov/federal-response/national-hiv-aids-strategy/nhas-update [verified 31 July 2015].
[3] Crosby R, Warner L. Pending research issues in male condom use promotion. Sex Health 2008; 5 317–919.
| Pending research issues in male condom use promotion.Crossref | GoogleScholarGoogle Scholar | 19061550PubMed |
[4] Curran JW, Crosby RA. Preexposure prophylaxis (PrEP): who will benefit and what are the challenges? Am J Prev Med 2013; 44 S163–6.
| Preexposure prophylaxis (PrEP): who will benefit and what are the challenges?Crossref | GoogleScholarGoogle Scholar | 23253761PubMed |
[5] Crosby RA, Mena L, Vickers-Smith R. Randomised controlled trial of a brief, clinic-based intervention to promote safer sex among young Black men who have sex with men: implications for pre-exposure prophylaxis-related counselling. Sex Health 2019; 16 187–91.
| Randomised controlled trial of a brief, clinic-based intervention to promote safer sex among young Black men who have sex with men: implications for pre-exposure prophylaxis-related counselling.Crossref | GoogleScholarGoogle Scholar | 30721647PubMed |
[6] Crosby RA. Dealing with pre-exposure prophylaxis-associated condom migration: changing the paradigm for men who have sex with men. Sex Health 2019; 14 106–10.
| Dealing with pre-exposure prophylaxis-associated condom migration: changing the paradigm for men who have sex with men.Crossref | GoogleScholarGoogle Scholar |
[7] Liu AY, Cohen SE, Vittinghof E, Anderson PL, Doblecki-Lewis S, Bacon O, et al Preexposure prophylaxis for HIV infection integrated with municipal- and community-based sexual health services. JAMA Intern Med 2016; 176 75–84.
| Preexposure prophylaxis for HIV infection integrated with municipal- and community-based sexual health services.Crossref | GoogleScholarGoogle Scholar | 26571482PubMed |
[8] Volk JE, Marcus JL, Phengrasamy T, Blechinger D, Nguyen DP, Follansbee S, et al No new HIV infections with increasing use of HIV preexposure prophylaxis in a clinical practice setting. Clin Infect Dis 2015; 61 1601–3.
| No new HIV infections with increasing use of HIV preexposure prophylaxis in a clinical practice setting.Crossref | GoogleScholarGoogle Scholar | 26334052PubMed |
